Form 4 for ARQT Arcutis Biotherapeutics, Inc.
Accepted 2022-12-09 00:00:00 ET · period of report 2022-12-07 · accession 0001787306-22-000079 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2022-12-09 | 2022-12-07 | ARQT | Watanabe Todd Franklin | See Remarks, Dir | S - Sale | $17.06 | -1,000 | 378.9K | -0.3% | -$17.1K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2022-12-07 | S | D | 1,000 | $17.06 | 378,907 | D | — | — |